Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
N2OFF to Expand its Melz Solar Project with Battery Storage
-
FOXO TECHNOLOGIES INC. ANNOUNCES ACQUISITION AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
-
Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement
-
BlockOffice Acquires Web3 Marketing Agency Powerhouse– ACTIV8 Lab (Previously Lydian Labs)– Organiser of Malaysia Blockchain Week
-
HPQ Awarded Up to $3M in Federal Funding to Fast-Track Commercialization of Silicon-Based Battery Materials
-
Apogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European Academy of Dermatology and V
-
Maze Therapeutics Announces Positive First-in-Human Results from Phase 1 Trial of MZE782, Establishing Proof of Mechanism for a Potent, Oral SLC6A19 Inhibitor with Potential to Treat Phenylketonuria (
-
Sky Quarry Appoints Co-Founder Marcus Laun as Interim Chief Executive Officer
-
Concentrix Schedules Release of Third Quarter 2025 Financial Results and Investor Conference Call Webcast
-
Watsco to Present at the 13th Annual Morgan Stanley Laguna Conference on September 11, 2025 at 4:50 p.m. PDT
-
WONZ Technology Showcases Innovative Product WONZ ta-VNS Device at IFA
-
More than 10,000 full-time college support staff on strike across Ontario: “We’re fighting for the future of student support.”
-
Luvme Hair 11th Anniversary: New Customers Get 30% Off and Free Shipping
-
Gilat Becomes First to Market with AI-Powered Network Management System
-
Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting
-
Pasinex Consolidates 100% Ownership of Horzum A.Ş.
-
Wrap Technologies Opens New Virginia Facility to Scale BolaWrap® and C-UAS Drone Solutions; Committed to All-American Made Production
-
A Landmark Pivotal Study Applying Precision Medicine to Psychiatry with Denovo’s DB104 (liafensine) for Treatment-Resistant Depression Published in JAMA Psychiatry
-
Methode Electronics Announces Leadership Updates in Accounting and Investor Relations
-
Premier American Uranium and Nuclear Fuels Provide Closing Update
-
Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company’s Plans to Drive Value Creation
-
Enovix Announces Pricing of $300.0 Million Offering of 4.75% Convertible Senior Notes Due 2030
-
Mobix Labs Advances Toward Peraso Acquisition After Positive Meeting with Management
-
OR Royalties Announces More Positive Developments on Select Assets
-
Solaris Strengthens Community Partnerships and Advances Key Milestones at Warintza Project
-
GURU Organic Energy Delivers Record Q3 2025 Results With Return to Profitability
-
Baker Hughes to Supply Integrated Subsea, Completion Systems for Turkish Petroleum’s Sakarya Gas Field Phase 3
-
The Lovesac Company Reports Second Quarter Fiscal 2026 Financial Results
-
Announcing the 2025 Fortune Best Workplaces by Industry
-
Tecnoglass Announces Third Quarter 2025 Dividend
-
Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204’s Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration
-
Sanoma plans to centralise its printing operations to the Helsinki area and close its printing facility in Tampere
-
FBS Analysis Shows Ethereum Positioning as Wall Street’s Base Layer
-
1.5 billion packets per second DDoS attack detected with FastNetMon
-
Magna Names Philip D. Fracassa Chief Financial Officer
-
Magna Names Philip D. Fracassa Chief Financial Officer
-
MediterraneanPlan.com Launches Complimentary 7-Day Meal Plan to Showcase the Health Benefits of the Mediterranean Lifestyle
-
K92 Mining Announces Major Regional Exploration Update: Significant Expansion of Arakompa Deposit, Discovery of Porphyry-Style Mineralization from Arakompa Southernmost Step-Out, and Substantial 3.5 k
-
Amesite Reports 63% Revenue Growth from NurseMagic™ Enterprise; Announces Launch of AI-Powered Government Form-Fill Automation to Reduce Reporting Burden
-
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
-
Anosh Ahmed, CEO of PFOAA, Presents New Industry Survey Revealing AI Adoption to Double in Financial Services by 2026
-
UTime Limited Announces Board Changes and Confirms Corporate Governance Stability
-
Hooker Furnishings Reports Fiscal 2026 Second Quarter Results
-
RadioMedix and Vect-Horus Announce First Patient Dosed in Exploratory Clinical Study of 203Pb-RMX-VH-PIB for Glioblastoma Multiforme and Pancreatic Ductal Adenocarcinoma
-
Canadians Considering Switching Banks and Lenders to Meet Their Credit and Mortgage Needs
-
South Star Announces Resignation of CEO
-
Defining a New Chapter for Urban Mobility in Europe with Avant-Garde Design and Unmissable Personalization
-
MEXC Enhances Futures Trading With Multi-Asset Margin Mode Across 14 Tokens
-
GenVivo Strengthens Oncology Leadership with Appointment of Noriyuki Kasahara, M.D., Ph.D., as Chief Scientific Officer
-
Ian Ball Appointed Vice-Chairman of McEwen Inc.
